- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Indian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
4
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
4 companies
Novartis India
Market Cap: ₹20.4b
Novartis India Limited is involved in the pharmaceutical business in India.
500672
₹824.50
7D
-2.4%
1Y
-19.4%
Quest Laboratories
Market Cap: ₹1.4b
Manufactures and sells pharmaceutical formulations in India.
QUESTLAB
₹87.80
7D
-1.0%
1Y
-25.2%
Curis Lifesciences
Market Cap: ₹1.1b
Operates as a pharmaceutical manufacturer, specializing in manufacturing of a wide range of pharmaceutical products, such as tablets, capsules, external preparations, oral liquid, and sterile ophthalmic ointments in India.
CURIS
₹140.70
7D
n/a
1Y
n/a
Shelter Pharma
Market Cap: ₹613.5m
Manufactures and sells pharmaceutical products for human and animals in India.
543963
₹41.28
7D
-1.9%
1Y
-21.5%